간편결제 가능보고서 주문 후, 연도 업데이트와 커스터마이징을 위해 당사에서 연락드릴 예정입니다.
상세 사항에 따라 가격이 변동될 수 있으니 참고 바랍니다.
기본 보고서는 영문으로 작성되며, PDF,PPT,DOCX(워드) 형식으로 제공 가능합니다.
보고서 전달 후에는 환불이 불가능하오니 양해 바랍니다.
평균 납기는 2주이며, 형식과 내용에 따라 달라질 수 있습니다.
요약
DNA 백신 시장은 2022-2027 년 기간 동안 33.86%의 CAGR로 증가하여 2027 년까지 943 억 달러 규모에 도달할 것으로 예상됩니다. DNA 백신은 항원을 암호화하고 부작용이 거의 없으며, 신체의 더 넓은 범위의 면역 반응을 자극하는 옥시리보핵산으로 구성됩니다.
Summary
DNA Vaccines Market. DNA Vaccines Market is forecast to reach revenue of $9.43 Billion by 2027, growing at a CAGR of 33.86% during the forecast period 2022-2027. DNA vaccines are composed of deoxyribonucleic acid, which encodes antigens and stimulates a wider range of immune responses in the body with few side effects
Table of Contents
1. DNA Vaccines Market Overview
1.1 Definitions and Scope
2. DNA Vaccines Market - Executive Summary
2.1 Market Revenue, and Key Trends by Company
2.2 Key trends by Type
2.3 Key trends by Technology
2.4 Key trends by Application
2.5 Key trends by Geography
3. DNA Vaccines Market – Comparative Analysis
3.1 Market Share Analysis- Key Companies
3.2 Product Benchmarking- Key Companies
3.3 Financial Analysis - Key Companies
3.4 Patent Analysis - Key Companies
3.5 Pricing Analysis
4. DNA Vaccines Market- Market Forces
4.1 Market Drivers
4.2 Market Constraints/Challenges
4.3 Porters Five Force Model
4.3.1 Bargaining Power of Suppliers
4.3.2 Bargaining Powers of Customers
4.3.3 Threat of New Entrants
4.3.4 Rivalry Among Existing Players
4.3.5 Threat of Substitutes
5. DNA Vaccines Market- Strategic Analysis
5.1 Value Chain Analysis
5.2 Opportunities Analysis
5.3 Market Life Cycle
6. DNA Vaccines Market – By Type (Market Size -$Million/$Billion)
6.1 DNA Vaccines for Humans
6.2 DNA Vaccines for Animals
7. DNA Vaccines Market – By Technology (Market Size -$Million/$Billion)
7.1 Plasmid DNA Vaccines Technology
7.1.1 Therapeutic Technology
7.1.2 Preventive Technology
7.2 Plasmid DNA Delivery Technology
7.2.1 Uncomplexed Plasmid DNA
7.2.2 Liposomes
7.2.3 Gold Particles
7.2.4 Electroporation
7.2.5 Bacteriophages
7.2.6 Bacterial ghosts
7.2.7 Nanoparticles
7.2.8 Viruses
8. DNA Vaccines Market – By Application (Market Size -$Million/$Billion)
8.1 Human Diseases
8.1.1 Oncology
8.1.1.1 Pancreatic Cancer
8.1.1.2 Breast Cancer
8.1.1.3 Ovarian Cancer
8.1.1.4 Small cell lung Cancer
8.1.1.5 Melanoma
8.1.1.6 Others
8.1.2 Infectious Diseases
8.1.2.1 Cytomegalovirus (CMV)
8.1.2.2 Hepatitis B (HBV)
8.1.2.3 Hepatitis C (HCV)
8.1.2.4 Human Immunodeficiency Virus (HIV)
8.1.2.5 Influenza
8.1.2.6 Others
8.1.3 Allergies
8.1.4 Others
8.2 Veterinary Disease
8.2.1 Canine Melanoma
8.2.2 Leishmaniasis
8.2.3 Equine West Nile Virus
8.2.4 Others
8.3 Others
9. DNA Vaccines Market - By Geography (Market Size -$Million/$Billion)
9.1 North America
9.1.1 U.S.
9.1.2 Canada
9.1.3 Mexico
9.2 South America
9.2.1 Brazil
9.2.2 Argentina
9.2.3 Rest of South America
9.3 Europe
9.3.1 U.K.
9.3.2 Germany
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia-Pacific
9.4.1 China
9.4.2 Japan
9.4.3 South Korea
9.4.4 India
9.4.5 Australia & New Zealand
9.4.6 Rest of Asia Pacific
9.5 Rest of the World
9.5.1 Middle East
9.5.2 Africa
9.5.3 South America
10. DNA Vaccines Market – Entropy
11. DNA Vaccines Market Company Analysis
11.1 Inovio Biomedical Corp.
11.2 Merck & Co.
11.3 Mitsubishi Tanabe
11.4 Dendreon Corporation
11.5 ASTELLAS PHARMA
11.6 Dynavax Technologies
11.7 Sanofi
11.8 Tekmira Pharmaceuticals
11.9 GlaxoSmithKline Corp
11.10 Protein Sciences Corp.
"*Financials for private companies would be provided on a best efforts basis”.
세금계산서 발행 문의
T. 070 8015 5940
보고서 주문 후, 연도 업데이트와 커스터마이징을 위해 당사에서 연락드릴 예정입니다.
상세 사항에 따라 가격이 변동될 수 있으니 참고 바랍니다.
기본 보고서는 영문으로 작성되며, PDF,PPT,DOCX(워드) 형식으로 제공 가능합니다.
보고서 전달 후에는 환불이 불가능하오니 양해 바랍니다.
평균 납기는 2주이며, 형식과 내용에 따라 달라질 수 있습니다.
요약
DNA 백신 시장은 2022-2027 년 기간 동안 33.86%의 CAGR로 증가하여 2027 년까지 943 억 달러 규모에 도달할 것으로 예상됩니다. DNA 백신은 항원을 암호화하고 부작용이 거의 없으며, 신체의 더 넓은 범위의 면역 반응을 자극하는 옥시리보핵산으로 구성됩니다.
Summary
DNA Vaccines Market. DNA Vaccines Market is forecast to reach revenue of $9.43 Billion by 2027, growing at a CAGR of 33.86% during the forecast period 2022-2027. DNA vaccines are composed of deoxyribonucleic acid, which encodes antigens and stimulates a wider range of immune responses in the body with few side effects
Table of Contents
1. DNA Vaccines Market Overview
1.1 Definitions and Scope
2. DNA Vaccines Market - Executive Summary
2.1 Market Revenue, and Key Trends by Company
2.2 Key trends by Type
2.3 Key trends by Technology
2.4 Key trends by Application
2.5 Key trends by Geography
3. DNA Vaccines Market – Comparative Analysis
3.1 Market Share Analysis- Key Companies
3.2 Product Benchmarking- Key Companies
3.3 Financial Analysis - Key Companies
3.4 Patent Analysis - Key Companies
3.5 Pricing Analysis
4. DNA Vaccines Market- Market Forces
4.1 Market Drivers
4.2 Market Constraints/Challenges
4.3 Porters Five Force Model
4.3.1 Bargaining Power of Suppliers
4.3.2 Bargaining Powers of Customers
4.3.3 Threat of New Entrants
4.3.4 Rivalry Among Existing Players
4.3.5 Threat of Substitutes
5. DNA Vaccines Market- Strategic Analysis
5.1 Value Chain Analysis
5.2 Opportunities Analysis
5.3 Market Life Cycle
6. DNA Vaccines Market – By Type (Market Size -$Million/$Billion)
6.1 DNA Vaccines for Humans
6.2 DNA Vaccines for Animals
7. DNA Vaccines Market – By Technology (Market Size -$Million/$Billion)
7.1 Plasmid DNA Vaccines Technology
7.1.1 Therapeutic Technology
7.1.2 Preventive Technology
7.2 Plasmid DNA Delivery Technology
7.2.1 Uncomplexed Plasmid DNA
7.2.2 Liposomes
7.2.3 Gold Particles
7.2.4 Electroporation
7.2.5 Bacteriophages
7.2.6 Bacterial ghosts
7.2.7 Nanoparticles
7.2.8 Viruses
8. DNA Vaccines Market – By Application (Market Size -$Million/$Billion)
8.1 Human Diseases
8.1.1 Oncology
8.1.1.1 Pancreatic Cancer
8.1.1.2 Breast Cancer
8.1.1.3 Ovarian Cancer
8.1.1.4 Small cell lung Cancer
8.1.1.5 Melanoma
8.1.1.6 Others
8.1.2 Infectious Diseases
8.1.2.1 Cytomegalovirus (CMV)
8.1.2.2 Hepatitis B (HBV)
8.1.2.3 Hepatitis C (HCV)
8.1.2.4 Human Immunodeficiency Virus (HIV)
8.1.2.5 Influenza
8.1.2.6 Others
8.1.3 Allergies
8.1.4 Others
8.2 Veterinary Disease
8.2.1 Canine Melanoma
8.2.2 Leishmaniasis
8.2.3 Equine West Nile Virus
8.2.4 Others
8.3 Others
9. DNA Vaccines Market - By Geography (Market Size -$Million/$Billion)
9.1 North America
9.1.1 U.S.
9.1.2 Canada
9.1.3 Mexico
9.2 South America
9.2.1 Brazil
9.2.2 Argentina
9.2.3 Rest of South America
9.3 Europe
9.3.1 U.K.
9.3.2 Germany
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia-Pacific
9.4.1 China
9.4.2 Japan
9.4.3 South Korea
9.4.4 India
9.4.5 Australia & New Zealand
9.4.6 Rest of Asia Pacific
9.5 Rest of the World
9.5.1 Middle East
9.5.2 Africa
9.5.3 South America
10. DNA Vaccines Market – Entropy
11. DNA Vaccines Market Company Analysis
11.1 Inovio Biomedical Corp.
11.2 Merck & Co.
11.3 Mitsubishi Tanabe
11.4 Dendreon Corporation
11.5 ASTELLAS PHARMA
11.6 Dynavax Technologies
11.7 Sanofi
11.8 Tekmira Pharmaceuticals
11.9 GlaxoSmithKline Corp
11.10 Protein Sciences Corp.
"*Financials for private companies would be provided on a best efforts basis”.
